Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
- Resource Type
- Article
- Authors
- Choueiri, Toni K; Escudier, Bernard; Powles, Thomas; Tannir, Nizar M; Mainwaring, Paul N; Rini, Brian I; Hammers, Hans J; Donskov, Frede; Roth, Bruce J; Peltola, Katriina; Lee, Jae Lyun; Heng, Daniel Y C; Schmidinger, Manuela; Agarwal, Neeraj; Sternberg, Cora N; McDermott, David F; Aftab, Dana T; Hessel, Colin; Scheffold, Christian; Schwab, Gisela; Hutson, Thomas E; Pal, Sumanta; Motzer, Robert J
- Source
- In The Lancet Oncology July 2016 17(7):917-927
- Subject
- Primary Research
Articles
- Language
- ISSN
- 1470-2045